about
Role of embB in natural and acquired resistance to ethambutol in mycobacteriaHeterogeneity and clonality among isolates of Mycobacterium kansasii: implications for epidemiological and pathogenicity studiesDraft Genome Sequences of Mycobacterium setense Type Strain DSM-45070 and the Nonpathogenic Strain Manresensis, Isolated from the Bank of the Cardener River in Manresa, Catalonia, SpainFluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococciGroup B streptococcal disease in nonpregnant adults: incidence, clinical characteristics, and outcome.Lab-on-Chip-Based Platform for Fast Molecular Diagnosis of Multidrug-Resistant Tuberculosis.[Application of mass spectrometry in mycobacteria].Mycobacteria Clumping Increase Their Capacity to Damage Macrophages.Additional data about the influence of an inhibitory factor on growth of Mycobacterium kansasii in BACTEC 12B medium.Factors associated with differences between conventional contact tracing and molecular epidemiology in study of tuberculosis transmission and analysis in the city of Barcelona, Spain.Advances in rapid diagnosis of tuberculosis disease and anti-tuberculous drug resistance.Inteins in mycobacterial GyrA are a taxonomic character.Increasing isolation of rapidly growing mycobacteria in a low-incidence setting of environmental mycobacteria, 1994-2015.Evaluation of the BACTEC MGIT 960 and the MB/BacT systems for recovery of mycobacteria from clinical specimens and for species identification by DNA AccuProbeImpaired fitness of Mycobacterium tuberculosis resistant isolates in a cell culture model of murine macrophages.QuantiFERON®-TB Gold In-Tube for contact screening in BCG-vaccinated adults: A longitudinal cohort study.Comparative in vitro activities of linezolid, telithromycin, clarithromycin, levofloxacin, moxifloxacin, and four conventional antimycobacterial drugs against Mycobacterium kansasii.Detection of interleukin-2 is not useful for distinguishing between latent and active tuberculosis in clinical practice: a prospective cohort study.Effectiveness of an integrated real-time PCR method for detection of the Mycobacterium tuberculosis complex in smear-negative extrapulmonary samples in an area of low tuberculosis prevalence.Evaluation of the VersaTREK system compared to the Bactec MGIT 960 system for first-line drug susceptibility testing of Mycobacterium tuberculosis.Trehalose Polyphleates, External Cell Wall Lipids in Mycobacterium abscessus, Are Associated with the Formation of Clumps with Cording Morphology, Which Have Been Associated with Virulence.Polyclonality among clinical strains of non-pigmented rapidly growing mycobacteria: phenotypic and genotypic differences and their potential implications.Molecular techniques in the diagnosis of drug-resistant tuberculosis.Use of a mycobacteriophage-based assay for rapid assessment of susceptibilities of Mycobacterium tuberculosis isolates to isoniazid and influence of resistance level on assay performance.QuantiFERON®-TB Gold In-Tube as a confirmatory test for tuberculin skin test in tuberculosis contact tracing: A non-inferiority clinical trial.Direct detection of Mycobacterium tuberculosis complex in clinical samples by a molecular method based on GenoQuick technology.GeneXpert® for smear-negative pulmonary tuberculosis: does it play a role in low-burden countries?Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis.Tuberculosis transmission patterns among Spanish-born and foreign-born populations in the city of Barcelona.A global gene pool for high-level cephalosporin resistance in commensal Streptococcus species and Streptococcus pneumoniae.Rapid detection of Mycobacterium tuberculosis complex and rifampin resistance in smear-negative clinical samples by use of an integrated real-time PCR method.First human isolate of Mycobacterium poriferae in the sputum of a patient with chronic bronchitis.Silent mutation in rpoB detected from clinical samples with rifampin-susceptible Mycobacterium tuberculosis.High rates of resistance to cephalosporins among viridans-group streptococci causing bacteraemia in neutropenic cancer patients.Characterization of the embB gene in Mycobacterium tuberculosis isolates from Barcelona and rapid detection of main mutations related to ethambutol resistance using a low-density DNA array.Tuberculosis in solid organ transplant patients.Diagnosis of tuberculosis infection by tuberculin skin test and a whole-blood interferon-γ release assay in patients considered for anti-tumor necrosis factor-α therapy.Use of a commercial double-test tablet (Rosco PGUA/indole) for screening of Escherichia coli.Mycobacterium kansasii disease among patients infected with human immunodeficiency virus type 1: improved prognosis in the era of highly active antiretroviral therapy.First human isolate of Mycobacterium madagascariense in the sputum of a patient with tracheobronchitis.
P50
Q28379175-CE042A93-831B-4C3D-BAD2-0446159484FBQ28776791-16C1EB5A-9668-4463-B867-B9AC00C086A5Q33457148-FE27E6B0-9759-4FC0-B3AB-F0AF472D0E36Q33700561-B8DB53C7-46D1-46E9-9737-C130DE83250AQ35676384-31DCDD85-CE2E-4363-BF32-440362DAC656Q35738433-17F48407-2638-46AA-BFAF-F9FD3024101BQ36070479-E076A31B-E1D3-46B0-98DF-10DB520CCC99Q36167179-B4B12A47-97C0-4BEF-A8BB-193446BD4AF7Q36528004-2344C5D1-C7A3-49FD-9A4B-39DC3133D4BFQ37051463-88D8B850-727C-470E-803C-1A73071C3CECQ37855147-DCE0AD8C-66BD-4C0C-8F5D-C49E08530FD2Q38553238-9D8BFE89-C255-4B17-BFBC-F0D653A1974BQ38742587-7C3CB684-A767-4D15-8E2A-C1DE76B01F90Q39468157-0AA958CB-E8C7-48A6-A9DA-9163859CED32Q39500528-9EC72332-AE62-44A6-B07D-EA80B76052CBQ40074673-3B70F177-C983-40DC-957E-EBB856B345CBQ40425898-838CB34B-0F4E-487A-B3F8-212D7782ED43Q40483579-D941FA55-24F6-4023-A55C-551055158ACDQ40598764-1A6EA4E8-792F-49DE-BEB0-CCD35A7A9BA3Q40599116-E3214DF6-51F9-4372-A4F5-FA7612AF1D22Q41108337-D5D4CF77-AD3A-49EA-BE0F-F10E92168CDBQ41537762-08FCA55C-53E0-4415-9413-19C6B511847EQ41717434-8E0515E0-8DAE-4EA3-AFBF-A9FC7984A5ECQ41902728-CA2FEC3D-71A2-4410-96B4-0C9B8E549EDBQ41987221-69451087-A5D9-4F81-B976-4A8D1B789E3FQ42081395-802F165C-B280-4BAA-A6AB-6721EC9DCF7AQ42280676-F5DF92D7-039D-415C-9EFF-9301FB3659D0Q42432121-9311FE6F-F310-4823-BBC0-1532D790FEF9Q42630708-ABE97F62-4A38-4248-991A-8794913C8E24Q42665294-22A087F2-0656-48D4-A1D7-E34D404C7A5BQ42706936-60D31D08-E7BA-4631-AFB3-8140916C110BQ42850044-08B5B68F-0687-4D1E-AC13-55D2CF1F021DQ42931671-63269B91-4203-488E-B744-5A2208585ADBQ43517836-F5A8539E-C7B6-40AC-8198-EC5A6C0F7F38Q44377904-23042438-FF92-49C4-8A30-1E84E3BC5C9CQ44902499-FE8D02F4-A5C6-4522-A725-89D60FEFD475Q45018309-87AE877A-19FA-4A4E-A3CA-74F463B9873FQ45712477-7F2CEC7C-265E-4BBC-92A2-6FB56BD83200Q45722527-14B9C1E5-48C7-49F3-BE76-CFBC8EB2A213Q45829293-CB8D3A05-2CAF-46F2-8A5C-9574D2284737
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Fernando Alcaide
@ast
Fernando Alcaide
@en
Fernando Alcaide
@es
Fernando Alcaide
@nl
Fernando Alcaide
@sl
type
label
Fernando Alcaide
@ast
Fernando Alcaide
@en
Fernando Alcaide
@es
Fernando Alcaide
@nl
Fernando Alcaide
@sl
prefLabel
Fernando Alcaide
@ast
Fernando Alcaide
@en
Fernando Alcaide
@es
Fernando Alcaide
@nl
Fernando Alcaide
@sl
P1053
B-4124-2015
P106
P21
P31
P3829
P496
0000-0002-4097-1499